Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: On December 24, 2009 we loaned $950,000 to TPL

You have a problem with this? I'd say it's a (lonely, at this point) feather in the BoD's cap.

The collateral is good, unless the MMP AND all of TPL's other assets are worthless, in which case it's game over for PTSC anyway.

10% in today's market is extremely good. They could alternatively get less than 2% with a CD, or 3.5% with 10yr. Treasuries.

It is in direct support of "monetizing the MMP".

Where's the problem????

The other (lonely) feather? They got Baroni & Co. for a reasonable fee. I feared the consultant fees would be much higher.

As for how "lonely" those cap feathers really are, as I said in my prior post, we won't really KNOW until the results of all divestitures are known, and until we see if Holocom and any other retained PDSG assets can turn a profit. Anything else is specualtion at its worst.

JMHOs,

SGE

Share
New Message
Please login to post a reply